MetaVista3D, Inc. ( (TSE:DDD) ) has shared an announcement.
Metavista3D Inc. has announced a 36-month collaboration with BrainBit, Inc. to integrate its pseudo-holographic 3D display technologies into BrainBit’s medical equipment. This partnership aims to transform clinical research by improving the interpretation of neurological and physiological data, potentially impacting the healthcare industry significantly. The collaboration underscores Metavista3D’s commitment to technological advancement and its vision of enhancing medical diagnostics through innovative visual experiences.
More about MetaVista3D, Inc.
Metavista3D Inc. operates in the healthcare technology industry, specializing in advanced 3D display technologies. With over three decades of experience in research and development, the company focuses on creating innovative solutions for both professional and consumer markets, aiming to enhance user experiences through AI-based displays.
YTD Price Performance: -23.01%
Average Trading Volume: 80,044
For an in-depth examination of DDD stock, go to TipRanks’ Stock Analysis page.